GrimyTimes.com - The Largest Criminal Database

Indivior Solutions Inc, Opioid Deception Scheme, Virginia 2023

Indivior Solutions, Inc. is facing a barrage of federal charges for its alleged role in a sprawling opioid crisis. At the center of the case is the company’s marketing and sales practices for its lucrative opioid addiction treatment medication Suboxone. Prosecutors claim that Indivior Solutions, Inc. engaged in a massive scheme to deceive doctors, patients, and regulators about the safety and efficacy of its product.

The case, United States v. Indivior Solutions, Inc., was filed in the Virginia federal court with docket number 20-cr-00027. The indictment alleges that Indivior Solutions, Inc. and its executives manipulated data, made false claims, and bribed doctors to prescribe Suboxone. The company’s actions, prosecutors argue, contributed significantly to the opioid epidemic that has ravaged communities across the country.

Indivior Solutions, Inc.’s alleged deception was not limited to its marketing materials. The company also allegedly falsified clinical trial data, downplayed the risks associated with its product, and hid information about the potential for addiction. These actions, prosecutors contend, put patients’ lives at risk and enabled Indivior Solutions, Inc. to reap massive profits from its opioid treatment medication.

The case against Indivior Solutions, Inc. has the potential to be a landmark prosecution, with far-reaching implications for the pharmaceutical industry. As the trial unfolds, it will be up to the court to determine the extent of Indivior Solutions, Inc.’s wrongdoing and the consequences it will face. One thing is clear: the public is watching, and the stakes are high.

Related Federal Cases

Key Facts

🔒 Get the grimiest stories delivered weekly. Subscribe free →

All Virginia Cases →
All Districts →

Posted

in

by